Telesair
Telesair, Inc. is a medical device company developing and commercializing respiratory care solutions — the Bonhawa High Flow Oxygen Therapy system and Avea disposable ventilator filters — for hospitals, health systems, and acute care facilities across the United States and Canada.
- Company typePrivate
- Founded2020
- HeadquartersIrvine, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Telesair does
Telesair, Inc. is a privately held medical device company headquartered in Irvine, California, founded in 2020 to develop respiratory care solutions for hospital and acute care settings. The company commercializes two products: the Bonhawa High Flow Oxygen Therapy (HFOT) System, its flagship standalone humidifier delivering warmed, humidified oxygen at flows of 2–80 L/min with three temperature settings (31°C, 34°C, 37°C), oxygen concentrations of 21–100%, and a proprietary Confirmed Therapy™ feature for real-time display of set-versus-delivered parameters; and the disposable Avea expiratory filter and water trap (Item 11790), acquired from Vyaire Medical in 2025 and FDA 510(k) cleared (K251133) in May 2025, serving the installed base of Vyaire Avea ventilators.
The business model centers on capital equipment sales of the Bonhawa device plus recurring single-use consumables (nasal cannulas, heated breathing circuits, water chambers, air filters). Pricing is quote-based and not publicly disclosed. Go-to-market is channel-driven: Tri-anim Health Services holds exclusive US distribution rights for Bonhawa under a May 2025 agreement, while Novus Medical is the Canadian distribution partner following Health Canada licensing in May 2025; Avea filters are sold directly via email inquiry and onboarding form.
The company has raised $22 million in Series A funding led by Pasaca Capital (January 2023) and filed an SEC Form D for an additional $6 million securities offering in March 2026. Leadership includes CEO and co-founder Don Lin, Ph.D. (former Mindray executive), President and COO Matt Margolies (appointed April 2025; ex-MGC Diagnostics, Cardinal Health), and CMO Dr. Shadi Battah. The company operates with 11–50 employees and MDSAP compliance to support multi-jurisdictional regulatory expansion.
Telesair firmographics
Firmographics- Name
- Telesair
- Legal name
- Telesair, Inc.
- Website
- https://telesair.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Telesair, Inc. is a medical device company developing and commercializing respiratory care solutions — the Bonhawa High Flow Oxygen Therapy system and Avea disposable ventilator filters — for hospitals, health systems, and acute care facilities across the United States and Canada.
- Ownership category
- akta.pro rank
Telesair industry classification
Industry- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Oxygen Therapy Systems (Concentrators, Cylinders, Liquid O2, HFNC) (HLAHAGAD)
- akta.pro secondary industries
- Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home) (HLAHAGAC), Noninvasive Ventilation Interfaces & Consumables (Masks, Tubing, Humidifiers, Filters) (HLAHAGAG), Respiratory & Sleep Therapy Equipment (Oxygen, CPAP/BiPAP, Nebulizers) (HSABAKAD)
Keywords
Where Telesair is headquartered
LocationHeadquarters
- HQ city
- Irvine
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Telesair business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Medical Device Hardware Sales: Sale of Bonhawa High Flow Oxygen Therapy systems and related capital equipment to hospitals and healthcare facilities. The device is sold with accessories including support arms, medical trolleys, and air filters.
- Consumables and Accessories: Recurring revenue from single-use consumables including nasal cannulas (Small, Medium, Large), heated breathing circuits, water chambers, and air filters. Consumables are replaced between patients for hygiene and optimal performance.
- Avea Filter Sales: Sale of disposable Avea expiratory filters and water traps (Box of 12, Item 11790) acquired from Vyaire Medical. These are single-use accessories for the Vyaire Avea ventilator system, supplied to hospitals and healthcare facilities.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Avea Filter - Box of 12 units (Item 11790) |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
Telesair product offering
Product offeringCore offering
Telesair designs, manufactures, and sells the Bonhawa High Flow Oxygen Therapy (HFOT) System — a standalone respiratory humidifier that delivers warmed, humidified, high-flow oxygen (2–80 L/min) to critically ill hospital patients as an alternative to non-invasive ventilation. The company also supplies consumable accessories, including the Avea Disposable Expiratory Filter (Water Trap) used with Vyaire Avea ventilators, providing a recurring revenue stream tied to installed ventilator bases.
Product overview
Telesair is a medical technology company offering two distinct respiratory care products: the Bonhawa High Flow Oxygen Therapy (HFOT) System as its flagship innovation, and the Avea Disposable Expiratory Filter / Water Trap acquired from Vyaire Medical. The Bonhawa is a standalone high flow oxygen therapy device designed by respiratory ventilation experts, featuring integrated oxygen delivery, temperature control, and humidity management for critically ill patients. The Avea filter complements the portfolio by serving the installed base of Vyaire Avea ventilators in hospitals. Both products target acute care hospital environments.
Differentiator
Problem solved
Functional benefit
Brands
- Bonhawa: High Flow Oxygen Therapy (HFOT) System - Telesair's flagship respiratory humidifier device designed to deliver comfortable, effective high-flow respiratory support to critically ill patients.
Quantifiable outcome
- Flows over 60 L/min associated with reduced respiratory rate and increased airway pressure for respiratory failure patients
- +3 more outcomes
Companies that use Telesair
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Telesair technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Telesair partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and major.
- Novus MedicalcoreCanadian distribution partnership for Bonhawa High Flow Oxygen Therapy device following Health Canada licensing. Novus Medical is an innovative, customer-centric distributor of respiratory, diagnostic, and critical care medical devices and supplies with over 40 years of experience in the Canadian healthcare market.
- Tri-anim Health ServicescoreExclusive US distribution agreement for Bonhawa High Flow Oxygen Therapy device. Tri-anim, a Sarnova company and leading specialty distributor of respiratory, anesthesia and critical care medical supplies, received exclusive rights to distribute Telesair's flagship product to hospitals, health systems, and acute care facilities across the United States. The partnership leverages Tri-anim's extensive national reach, specialized sales force, and strong relationships within the acute care market.
- Vyaire MedicalmajorTelesair acquired regulatory and commercial ownership of the Avea filter product line from Vyaire Medical. Telesair received FDA 510(k) clearance for the disposable Avea expiratory filter and water trap, ensuring continued availability of these critical components for the widely used Vyaire Avea ventilator system.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
Telesair competitors and assessment
Company assessmentBroad incumbents
- Mindray: Global medical-device manufacturer with hospital ventilation, patient monitoring, and anesthesia offerings. Highly relevant given that Telesair CEO Don Lin previously led product development and IP strategy at Mindray.
- ResMed: Global respiratory-care leader spanning hospital ventilation, HFOT, and sleep apnea. Telesair's Bonhawa competes with ResMed's hospital respiratory portfolio, and ResMed's scale and clinical evidence base make it a primary competitive benchmark.
- Teleflex: Diversified medical-device company with a respiratory-care franchise (including HFOT interfaces and ventilation accessories) serving the same hospital and acute-care channels Telesair targets.
- Philips Respironics: Major hospital respiratory and ventilation franchise (including HFOT and noninvasive ventilation). Telesair competes with Philips in hospital HFOT and broader respiratory care despite Philips' much wider portfolio.
- Dräger: Broad medical-safety and ventilation portfolio including ICU ventilators, anesthesia delivery, and patient monitoring. Comparable to Telesair in the respiratory/ventilation category within a much larger hospital-equipment business.
- Getinge: Hospital-care company with mechanical ventilation, anesthesia, and ICU infrastructure. Comparable as an established respiratory and critical-care vendor competing for hospital capital equipment budgets.
Direct peers
- Vyaire Medical: Manufacturer of the Avea ventilator line whose installed base Telesair now serves through the acquired Avea filter business. Comparable as a respiratory/ventilation device specialist operating in the same acute-care channel.
- Fisher & Paykel Healthcare: Global leader in high-flow oxygen therapy (Optiflow/Airvo) and heated humidified respiratory care for hospital and home. Direct competitor to Telesair's Bonhawa HFOT system across the same hospital and acute-care customer segment.
- Hamilton Medical: Specialist in mechanical ventilation and intelligent ventilation technologies for ICUs. Directly comparable as a respiratory-device pure-play focused on acute-care and critical-care ventilation.
Emerging players
- Maxtec: Specialty manufacturer of respiratory therapy accessories including oxygen blenders, flowmeters, and air-O2 mixers. Comparable as a smaller, focused respiratory device/accessory company serving acute and sub-acute care customers.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Telesair social profiles
Digital presenceTelesair compliance and trust
Trust signalCompliance4 records
Telesair financial estimates
Financial estimateRevenue estimate
Valuation estimate
Telesair leadership team
Management profileNumber of profiles
Profiles4 records
Telesair funding detail
Funding detailFunding overview
Funding rounds2 records
Investors7 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Telesair M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Telesair
What does Telesair do?
Telesair designs, manufactures, and sells the Bonhawa High Flow Oxygen Therapy (HFOT) System — a standalone respiratory humidifier that delivers warmed, humidified, high-flow oxygen (2–80 L/min) to critically ill hospital patients as an alternative to non-invasive ventilation. The company also supplies consumable accessories, including the Avea Disposable Expiratory Filter (Water Trap) used with Vyaire Avea ventilators, providing a recurring revenue stream tied to installed ventilator bases.
Is Telesair a public or private company?
Telesair is a private company. It is currently operating.
When was Telesair founded?
Telesair was founded in 2020. It employs 11 to 50 people.
Where is Telesair based?
Telesair is headquartered in Irvine, United States, in the North America region.
How does Telesair make money?
Three revenue lines are on record. Medical Device Hardware Sales are the primary driver. The others are consumables and Accessories and avea Filter Sales.
Who are Telesair's main competitors?
Broad incumbents on record are Mindray, ResMed, Teleflex, Philips Respironics, Dräger and Getinge. Direct peers are Vyaire Medical, Fisher & Paykel Healthcare and Hamilton Medical. Maxtec is listed as an emerging player.
Does Telesair have an API?
No public API is recorded for Telesair.
What industry is Telesair in?
Its primary akta.pro industry code is HLAHAGAD, Oxygen Therapy Systems (Concentrators, Cylinders, Liquid O2, HFNC), with a secondary code of HLAHAGAC, Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home). Its NAICS code is 334510 and its SIC code is 3845.